Cargando…
Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy
Early identification of breast cancer (BC) patients at a high risk of progression may aid in therapeutic and prognostic aims. This is especially true for metastatic disease, which is responsible for most cancer-related deaths. Growing evidence indicates that the translationally controlled tumor prot...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
OAE Publishing Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571059/ https://www.ncbi.nlm.nih.gov/pubmed/37842235 http://dx.doi.org/10.20517/cdr.2023.21 |